Orocecal transit delay in obese patients
Authors:
- 1 April 1989
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 34 (4) , 509-512
Abstract
Orocecal transit time was assessed with lactulose hydrogen breath test in 12 obese patients during intravenous infusion of placebo or naloxone 40 μg/kg/hr given in randomized order and in double-blind conditions. Transit time was also evaluated in 22 healthy controls. Orocecal transit was significantly (P<0.01) longer in the obese patients during placebo treatment (median 130, range 100–200 min) than in the healthy controls (median 75, range 40–170 min). Compared with placebo, transit time in the obese subjects was delayed (P<0.05) during naloxone treatment (median 150, range 100–230 min).Keywords
This publication has 29 references indexed in Scilit:
- Oral naloxone antagonizes loperamide-induced delay of orocecal transitDigestive Diseases and Sciences, 1987
- Effects of morphine and naloxone on esophageal motility and gastric emptying in manDigestive Diseases and Sciences, 1986
- Effect of Naloxone on Food Consumption in ObesityNew England Journal of Medicine, 1985
- Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test.Gut, 1985
- Fenfluramine delays gastric emptying of solid food.1985
- Hyperinsulinemia in obesity: Lack of relation to gastric emptying of glucose solution or to plasma somatostatin levelsMetabolism, 1983
- Respiratory excretion of hydrogen and methane in Italian subjects after ingestion of lactose and milkEuropean Journal of Clinical Investigation, 1983
- Naloxone and morphine inhibit gastric emptying of solidsCanadian Journal of Physiology and Pharmacology, 1982
- On the specificity of naloxone as an opiate antagonistLife Sciences, 1979
- Gastric emptying in diabetic autonomic neuropathy.Gut, 1977